3-66394191-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_015541.3(LRIG1):c.1317C>T(p.Ser439Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 1,593,816 control chromosomes in the GnomAD database, including 50,915 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 7842 hom., cov: 33)
Exomes 𝑓: 0.24 ( 43073 hom. )
Consequence
LRIG1
NM_015541.3 synonymous
NM_015541.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.312
Genes affected
LRIG1 (HGNC:17360): (leucine rich repeats and immunoglobulin like domains 1) Predicted to act upstream of or within several processes, including innervation; otolith morphogenesis; and sensory perception of sound. Predicted to be located in plasma membrane. Predicted to be active in extracellular matrix and extracellular space. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 3-66394191-G-A is Benign according to our data. Variant chr3-66394191-G-A is described in ClinVar as [Benign]. Clinvar id is 403056.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.312 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.456 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRIG1 | NM_015541.3 | c.1317C>T | p.Ser439Ser | synonymous_variant | 12/19 | ENST00000273261.8 | NP_056356.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRIG1 | ENST00000273261.8 | c.1317C>T | p.Ser439Ser | synonymous_variant | 12/19 | 1 | NM_015541.3 | ENSP00000273261.3 | ||
LRIG1 | ENST00000383703.3 | c.1389C>T | p.Ser463Ser | synonymous_variant | 13/20 | 1 | ENSP00000373208.3 | |||
LRIG1 | ENST00000495037.1 | n.333C>T | non_coding_transcript_exon_variant | 4/11 | 2 | |||||
LRIG1 | ENST00000496559.6 | n.699C>T | non_coding_transcript_exon_variant | 5/12 | 2 |
Frequencies
GnomAD3 genomes AF: 0.301 AC: 45691AN: 152042Hom.: 7822 Cov.: 33
GnomAD3 genomes
AF:
AC:
45691
AN:
152042
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.258 AC: 59760AN: 231390Hom.: 8621 AF XY: 0.249 AC XY: 31067AN XY: 124748
GnomAD3 exomes
AF:
AC:
59760
AN:
231390
Hom.:
AF XY:
AC XY:
31067
AN XY:
124748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.237 AC: 341994AN: 1441656Hom.: 43073 Cov.: 33 AF XY: 0.235 AC XY: 168349AN XY: 716058
GnomAD4 exome
AF:
AC:
341994
AN:
1441656
Hom.:
Cov.:
33
AF XY:
AC XY:
168349
AN XY:
716058
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.301 AC: 45758AN: 152160Hom.: 7842 Cov.: 33 AF XY: 0.300 AC XY: 22318AN XY: 74370
GnomAD4 genome
AF:
AC:
45758
AN:
152160
Hom.:
Cov.:
33
AF XY:
AC XY:
22318
AN XY:
74370
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
607
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
LRIG1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at